Global Rat Model Market to Surpass $ 1.8 Bn by 2025

January 21, 2020


According to the research report titled ‘Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report LLC, the global rat model market is expected to cross USD 1.8 billion by the year 2025.
 

Increasing utilization of rats for development of vaccines is a major factor driving the rat model market growth. Rat models are used to study the prevalence and development of diseases since rats and humans have several functional resemblances. Rats are also utilized for mechanistic analysis of reproduction in humans. Increasing drug testing on rats in order to ensure safe administration in humans is stimulating the industry outlook.
 

Rising adoption of rats with the aim of conducting cognitive research studies regarding autoimmune diseases, cardiovascular diseases, and cancer is aiding the expansion of rat model market. The burgeoning demand for personalized humanized rat models on account of surging inclination towards personalized medicines, together with expanding deployment of rat model in drug discovery will enhance the remuneration potential of this market.  
 

As per rat type, the report cites that the inbred rat model market segment held 25% share in the year 2018. Rat models help in simulating autoimmune diseases and offer additional tissue samples as compared to its counterpart. This helps researchers to analyze the disease mechanism in the human body. Rising adoption of rat models in research for autoimmune diseases are facilitating the business scenario.
 

In terms of technology, the CRISPR technology segment held 31.5% share of the overall market in 2018. This technology helps to alter target genes. Moreover, CRISPR technology provides benefits such as time-saving, enhanced efficiency, convenience, and cost effectiveness. Growing demand for CRISPR rat model technology in several biotechnology centers is thus fueling the segmental growth.
 

Based on application spectrum, the research & development application segment accounted for 72.2% share of the market in the year 2018. Since rats can memorize several types of task, researchers are able to perform various studies on the animals related to learning and memory. Growing demand for rat models in R&D activities is therefore boosting the growth of the segment.
 

By use, the human use segment accounted for 80% share in the rat model industry in the year 2018. This is due to high frequency of testing procedures on rats for studying diabetes and cardiovascular diseases which can affect humans.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2419637/
 

Citing end-use, the companies segment accounted for 61.2% share in rat model industry in the year 2018. Rising R&D activities in pharma and biotech industries along with development of state-of-the-art vaccines are aiding the market expansion.
 

As per regional analysis, the U.S. rat model industry is presumed to grow with 8% CAGR between the year 2019-2025. Rising number of physiological tests by research institutes has augmented the demand for rat models across the country.
 

TransViragen Inc., Transposagen Biopharmaceuticals Inc., Taconic Biosciences Inc., Janvier Labs, Horizon Discovery Group Plc, Biomere, genOway, Envigo, and Charles River are the prominent companies operating in the rat model market.


Frequently Asked Questions (FAQ) :

Increasing utilization of rats for development of vaccines is a major factor driving the rat model market growth. Rat models are used to study the prevalence and development of diseases since rats and humans have several functional resemblances. Rats are also utilized for mechanistic analysis of reproduction in humans. Increasing drug testing on rats in order to ensure safe administration in humans is stimulating the industry outlook. Rising adoption of rats with the aim of conducting cognitive research studies regarding autoimmune diseases, cardiovascular diseases and cancer is aiding the expansion of rat model market. The burgeoning demand for personalized humanized rat models on account of surging inclination towards personalized medicines, together with expanding deployment of rat model in drug discovery will enhance the remuneration potential of this market.
The report cites that the inbred rat model market segment held 25% share in the year 2018. Rat models help in simulating autoimmune diseases and offer additional tissue samples as compared to its counterpart. This helps researchers to analyze the disease mechanism in the human body. Rising adoption of rat models in research for autoimmune diseases are facilitating the business scenario.
The U.S. rat model industry is presumed to grow with 8% CAGR between the year 2019-2025. Rising number of physiological tests by research institutes has augmented the demand for rat models across the country.
TransViragen Inc., Transposagen Biopharmaceuticals Inc., Taconic Biosciences Inc., Janvier Labs, Horizon Discovery Group Plc, Biomere, genOway, Envigo and Charles River are the prominent companies operating in the rat model market.